1.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SP-BC-01, NCI-V96-0813
|
|
2.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 17 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SP-MM-01, NCI-V96-0814
|
|
3.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FRE-IGR-T89-0069, NCI-T89-0069A, T89-0069
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8733, NCI-T87-0085C, T87-0085
|
|
5.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8735, NCI-T87-0089H, T87-0089
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-94-C-0207A, NCI-T94-0095N, T94-0095
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-DS-96-26, UTHSC-9235011358, NCI-T94-0043D, NCT00002578, T94-0043
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1896, E1896
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-81107
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7911
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7912
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7917
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7923
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7940/43
|
|
15.
|
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-82100C, NCI-W82-1435, W82-1435
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor:
Protocol IDs: MSKCC-82137B
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-82138, NCI-C83-0464
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 17 and over
Sponsor: NCI
Protocol IDs: MSKCC-8344, NCI-T83-1093D, T83-1093
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SEG-79RLPD267
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-MM-82292
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7916
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-82143
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8394, NCI-T83-1211C, T83-1211
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI
Protocol IDs: UCHSC-GN-1, NCI-T84-0335D, T84-0335
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-208
|
Mobile | Español
